Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Unigen divulges tyrosinase and melanin inhibitors

May 6, 2020

Phase II trial of nomacopan in bullous pemphigoid meets primary and key secondary efficacy endpoints

May 4, 2020

Pfizer discloses new PDE4B inhibitors

April 24, 2020

Phase IIb study of Rivelin-CLO achieves primary endpoint

April 24, 2020

Amryt closes enrollment in phase III EASE trial of AP-101 for epidermolysis bullosa

April 23, 2020

Phase II study of vixarelimab in prurigo nodularis meets primary efficacy endpoint

April 23, 2020

Arcutis initiates phase I/IIb study of ARQ-252 for chronic hand eczema

April 22, 2020

Shenzhen Edk Pharmaceutical Technology patents androgen receptor antagonists

April 16, 2020

Positive topline data from phase I clinical study of BX-001

April 1, 2020

SMOC1 as a novel therapeutic target in atopic dermatitis

March 31, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...